Kappa Light Chain refers to one of the two major immunoglobulin light chain types found in antibodies, paired with heavy chains to form functional immunoglobulin molecules. Light chains contribute to antigen binding and overall antibody structure, with kappa and lambda representing alternative light chain classes in humans. Measurement of free kappa light chains in blood is clinically relevant for diagnosing and monitoring plasma cell disorders.
The biopharmaceutical industry considers kappa light chain biology in antibody discovery, engineering, and clinical diagnostics. Therapeutic monoclonal antibodies may use kappa light chains depending on sequence selection and manufacturability characteristics. Analytical characterisation confirms correct assembly, disulphide bonding, and integrity of light chain components during production. In clinical settings, free light chain assays support monitoring of multiple myeloma and related conditions, influencing treatment decisions and disease staging. Understanding kappa light chain properties supports both therapeutic antibody development and diagnostic applications within immunology and oncology.
General Biopharmaceutical Concepts
Kappa Light Chain
A kappa light chain is one of the two classes of immunoglobulin light chains that forms part of the structure and antigen-binding region of antibodies.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →